VGLL3
Basic information
Region (hg38): 3:86876388-86991149
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VGLL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 3 | 0 |
Variants in VGLL3
This is a list of pathogenic ClinVar variants found in the VGLL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-86968637-G-C | not specified | Uncertain significance (Mar 04, 2024) | ||
3-86968640-C-A | not specified | Uncertain significance (Dec 18, 2023) | ||
3-86968650-C-T | not specified | Uncertain significance (May 03, 2023) | ||
3-86968710-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
3-86968746-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
3-86968770-A-T | not specified | Uncertain significance (Jan 22, 2024) | ||
3-86968776-C-A | not specified | Uncertain significance (Feb 09, 2023) | ||
3-86968812-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
3-86968857-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
3-86968884-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
3-86968905-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
3-86968934-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
3-86969057-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
3-86969057-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
3-86969099-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-86969100-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
3-86969120-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
3-86978548-C-A | not specified | Uncertain significance (Aug 02, 2022) | ||
3-86978565-T-A | not specified | Uncertain significance (Apr 20, 2024) | ||
3-86978691-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
3-86978700-G-T | not specified | Uncertain significance (Oct 24, 2023) | ||
3-86978702-T-G | not specified | Uncertain significance (Oct 24, 2023) | ||
3-86978704-T-C | Likely benign (May 01, 2023) | |||
3-86990639-C-T | Likely benign (Jul 01, 2022) | |||
3-86990641-G-T | not specified | Uncertain significance (Nov 29, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VGLL3 | protein_coding | protein_coding | ENST00000398399 | 4 | 53151 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0697 | 0.918 | 124797 | 0 | 10 | 124807 | 0.0000401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.217 | 175 | 183 | 0.955 | 0.00000938 | 2113 |
Missense in Polyphen | 28 | 47.594 | 0.58831 | 589 | ||
Synonymous | -0.869 | 79 | 69.8 | 1.13 | 0.00000371 | 649 |
Loss of Function | 2.19 | 4 | 12.3 | 0.325 | 6.06e-7 | 147 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000180 | 0.000180 |
Ashkenazi Jewish | 0.0000993 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000355 | 0.0000353 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a specific coactivator for the mammalian TEFs. {ECO:0000250|UniProtKB:Q8N8G2}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.340
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63
Haploinsufficiency Scores
- pHI
- 0.0694
- hipred
- N
- hipred_score
- 0.214
- ghis
- 0.565
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vgll3
- Phenotype
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function